GPC3 and hepatocellular carcinoma: Based on our experience in EHBH, the immunohistochemical sensitivity of GPC3 in 3,232 cases of HCC (from August 2010 to July 2011) was only 63.1%, while those of HSP70 and GS were not as high as expected (data not shown).